Lung Cancer News

Researchers at UT Southwestern Medical Center have introduced a new metric that may be useful in predicting which patients are likely to develop immunotherapy toxicity.

The American Cancer Society has updated its lung cancer screening guideline to recommend yearly lung cancer screening for asymptomatic smokers or previous smokers aged 50 to 80 years with a 20-year or greater pack-year history.

An estimated 10% to 40% of patients with solid tumors develop brain metastases.

The FDA granted accelerated approval to entrectinib for infants aged 1 month and older who have solid tumors that harbor neurotrophic tyrosine receptor kinase, or NTRK, gene fusion for whom there are no effective treatments.

MADRID — The combination of amivantamab and lazertinib improved PFS compared with osimertinib as first-line treatment for EGFR-mutated advanced non-small cell lung cancer, according to study results presented at ESMO Congress.

MADRID — The addition of amivantamab to first-line chemotherapy improved outcomes for patients with advanced non-small cell lung cancer and EGFR exon 20 insertions, according to randomized phase 3 study results presented at ESMO Congress.

MADRID — The addition of nivolumab to neoadjuvant chemotherapy, followed by adjuvant nivolumab, improved outcomes for patients with untreated resectable non-small cell lung cancer, randomized phase 3 study results showed.

MADRID — Tarlatamab exhibited antitumor activity among patients with small cell lung cancer who received prior treatment, according to results of the DeLLphi-301 study presented at ESMO Congress.

Greater travel time appeared associated with reduced participation in genotype-matched clinical trials among patients with cancer who underwent comprehensive genomic profiling, according to results of a study conducted in Japan.

The FDA approved pembrolizumab plus platinum-containing chemotherapy as neoadjuvant therapy, followed by single-agent pembrolizumab as adjuvant therapy after surgery for adults with resectable non-small cell lung cancer.